1. Home
  2. EDSA vs MGRX Comparison

EDSA vs MGRX Comparison

Compare EDSA & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • MGRX
  • Stock Information
  • Founded
  • EDSA 2015
  • MGRX 2021
  • Country
  • EDSA Canada
  • MGRX United States
  • Employees
  • EDSA N/A
  • MGRX N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • MGRX Computer Software: Prepackaged Software
  • Sector
  • EDSA Health Care
  • MGRX Technology
  • Exchange
  • EDSA Nasdaq
  • MGRX Nasdaq
  • Market Cap
  • EDSA 6.2M
  • MGRX 6.3M
  • IPO Year
  • EDSA N/A
  • MGRX 2023
  • Fundamental
  • Price
  • EDSA $2.43
  • MGRX $4.33
  • Analyst Decision
  • EDSA Strong Buy
  • MGRX
  • Analyst Count
  • EDSA 1
  • MGRX 0
  • Target Price
  • EDSA $21.00
  • MGRX N/A
  • AVG Volume (30 Days)
  • EDSA 5.9M
  • MGRX 163.8K
  • Earning Date
  • EDSA 02-14-2025
  • MGRX 03-31-2025
  • Dividend Yield
  • EDSA N/A
  • MGRX N/A
  • EPS Growth
  • EDSA N/A
  • MGRX N/A
  • EPS
  • EDSA N/A
  • MGRX N/A
  • Revenue
  • EDSA N/A
  • MGRX $755,000.00
  • Revenue This Year
  • EDSA N/A
  • MGRX N/A
  • Revenue Next Year
  • EDSA N/A
  • MGRX N/A
  • P/E Ratio
  • EDSA N/A
  • MGRX N/A
  • Revenue Growth
  • EDSA N/A
  • MGRX 52.20
  • 52 Week Low
  • EDSA $1.55
  • MGRX $2.07
  • 52 Week High
  • EDSA $5.59
  • MGRX $16.80
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 56.54
  • MGRX 58.08
  • Support Level
  • EDSA $2.30
  • MGRX $3.90
  • Resistance Level
  • EDSA $4.49
  • MGRX $6.15
  • Average True Range (ATR)
  • EDSA 0.30
  • MGRX 0.58
  • MACD
  • EDSA 0.05
  • MGRX 0.08
  • Stochastic Oscillator
  • EDSA 22.56
  • MGRX 44.76

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About MGRX Mangoceuticals Inc.

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Share on Social Networks: